Lucio Iannone, PhD
Lucio Iannone is Director Venture Investments of Leaps by Bayer, where he is responsible for developing investment cases and deal execution. He is also involved in sourcing, screening, and mentoring of companies with game-changing science. Before joining Bayer, Lucio Iannone had several senior roles in biotechnology companies and venture capital firms. He has experience with molecular biology, cell & gene therapy technologies and their application in oncology and other therapeutic fields. Lucio Iannone began his career as a cardiovascular scientist at Imperial college of London in the department of experimental medicine where he received his Ph.D.